Showing 1 - 9 results of 9 for search 'Francesca Guijarro', query time: 0.03s
Refine Results
-
1
Novel Tools for Diagnosis and Monitoring of AML by Francesca Guijarro, Marta Garrote, Neus Villamor, Dolors Colomer, Jordi Esteve, Mónica López-Guerra
Published 2023-05-01
Article -
2
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia by Laia Cuesta-Casanovas, Jennifer Delgado-Martínez, Josep M. Cornet-Masana, José M. Carbó, Antònia Banús-Mulet, Francesca Guijarro, Jordi Esteve, Ruth M. Risueño
Published 2023-05-01
Article -
3
Infrequent Presentations of Chronic <i>NPM1</i>-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature by Sandra Castaño-Díez, Francesca Guijarro, Mònica López-Guerra, Amanda Isabel Pérez-Valencia, Marta Gómez-Núñez, Dolors Colomer, Marina Díaz-Beyá, Jordi Esteve, María Rozman
Published 2024-02-01
Article -
4
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing by Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larrán
Published 2023-07-01
Article -
5
P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING by Marta Garrote Ordeig, Monica Lopez-Guerra, Eduardo Arellano-Rodrigo, Maria Rozman, Sara Carbonell Ordeig, Francesca Guijarro, Marta Santaliestra Tomas, Ana Triguero Moreno, Dolors Colomer, Francisco Cervantes, Alberto Alvarez Larran
Published 2023-08-01
Article -
6
P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMET... by Carlos Jimenez-Vicente, Francesca Guijarro, Monica Lopez-Guerra, Ares Guardia-Torrelles, Alexandra Martínez Roca, Alex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Dolors Colomer, Marina Diaz-Beya, Jordi Esteve
Published 2023-08-01
Article -
7
PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS by Ares Guardia-Torrelles, Carlos Jimenez-Vicente, Alexandra Martínez Roca, Sandra Castaño-Díez, Helena Brillembourg, Francesca Guijarro, Àlex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Marina Diaz-Beya, Jordi Esteve, Beatriz Merchan
Published 2023-08-01
Article -
8
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes by Sandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, Daniel Esteban, Francesca Guijarro, Carlos Jiménez-Vicente, Carlos Castillo-Girón, Albert Cortes, Alexandra Martínez-Roca, Ana Triguero, José Ramón Álamo, Silvia Beà, Dolors Costa, Dolors Colomer, María Rozman, Jordi Esteve, Marina Díaz-Beyá
Published 2022-08-01
Article -
9
P1356: CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES by Lorenza Pérez Amill, Mercedes Armand Ugon, Sergio Peña Pérez, Maria Val Casals, Claudio Santos, Gerard Frigola, José Ramon Álamo, Francesca Guijarro, Alfredo Minguela, Àlex Bataller, Juan Gonzalo Correa Saldarriaga, Berta Casanovas Albertí, Mireia Uribe Herranz, Europa Azucena Gonzalez, Daniel Benitez-Ribas, Diego Sanchez, Nestor Tirado, Paola Romecin, Talía Velasco, Pablo Menendez, Antonio Martínez, Montserrat Rovira Tarrats, Jordi Esteve, Avaro Urbano Ispizua, Julio Delgado, Manel Juan, Nela Klein González
Published 2023-08-01
Article